文献速递外周动脉疾病

严重踝下病变是慢性肢体威胁性缺血血管内血运重建后不良肢体结局的独立预测因素

Severe inframalleolar disease is an independent predictor of adverse limb outcomes after endovascular revascularization in chronic limb-threatening ischemia.
PubMed 文献 · J Vasc Surg · 2022-11-01

本研究回顾性分析2015年1月至2019年12月在两所大学附属医院因慢性肢体威胁性缺血行血管内血运重建的167条肢体(149例患者),比较严重踝下病变(足部评分2分)与轻中度病变(0或1分)患者的结局。结果显示严重踝下病变占43%,与无主要不良肢体事件生存率较低相关(69% vs 82%;P = .026),且为主要不良肢体事件和截肢风险的独立预测因素(HR 1.715;95%CI 1.015-2.896;P = .044)。

要点

  • 严重踝下病变存在于43%因慢性肢体威胁性缺血行血管内血运重建的肢体中。
  • 严重踝下病变与较低的无主要不良肢体事件生存率相关(69% vs 82%;P = .026)。
  • 严重踝下病变独立增加主要不良肢体事件和截肢风险(HR 1.715;95%CI 1.015-2.896;P = .044)。

核心结论

  • 严重踝下病变在因慢性肢体威胁性缺血行血管内血运重建的肢体中占43%,与较低的无主要不良肢体事件生存率相关。
  • 严重踝下病变独立增加慢性肢体威胁性缺血患者不良肢体结局和截肢的风险超过70%,突显其作为足部灌注指标的重要性。

研究设计与样本

  • 回顾性研究,纳入2015年1月至2019年12月在两所大学附属医院因慢性肢体威胁性缺血行血管内血运重建的患者。
  • 共纳入149例患者的167条肢体(女性36%;平均年龄74 ± 12岁),严重踝下病变71条肢体(43%),轻中度病变为0或1分。
  • 主要结局为主要不良肢体事件(开放血运重建、急性腿缺血、大截肢),次要结局包括死亡、再干预、主要不良心脏事件、围手术期并发症(≤30天)、主要肢体通畅性和任何肢体事件。

主要发现

  • 基线特征除严重踝下病变组血脂异常患病率较高外(66% vs 43%;P = .003),其余无差异。
  • 两组WIfI评分4分(严重踝下病变64% vs 轻中度57%;P = .462)和GLASS III级解剖(严重踝下病变54% vs 轻中度48%;P = .752)无差异。
  • Kaplan-Meier估计显示严重踝下病变与较低的无主要不良肢体事件生存率相关(69% vs 82%;P = .026)。
  • Cox比例风险回归模型显示,校正协变量后严重踝下病变是主要不良肢体事件和截肢风险的独立预测因素(HR 1.715;95%CI 1.015-2.896;P = .044)。
  • 随访期间严重踝下病变组与轻中度组死亡(27% vs 31%;P = .567)、再干预(42% vs 38%;P = .608)和主要肢体通畅性(79% vs 84%;P = .593)相似,平均随访3.8 ± 0.8年。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In the present study, we evaluated the effects of inframalleolar (IM) disease on the occurrence of major adverse limb events (MALE) in patients undergoing endovascular revascularization for chronic limb-threatening ischemia (CLTI). METHODS: Patients who had undergone endovascular revascularization for CLTI between January 2015 and December 2019 at two university-affiliated hospitals were reviewed retrospectively. Patients with severe IM disease (pedal score of 2) were compared with those with mild to moderate IM disease (score of 0 or 1) using the Global Vascular Guidelines. The primary outcome was MALE (open revascularization, acute leg ischemia, major amputation). The secondary outcomes were mortality, reintervention, major adverse cardiac events, and perioperative complications ≤30 days after endovascular revascularization, primary limb-based patency, and the occurrence of any limb event (defined as any amputation, acute leg ischemia, or open revascularization). Kaplan-Meier estimates were used to compare the primary outcome, and the Cox proportion hazard model was used to assess the effects of IM disease. RESULTS: The study included 167 limbs in 149 patients (36% female; mean age, 74 ± 12 years). Severe IM disease was identified in 71 limbs (43%). No differences were found in the baseline characteristics, except for a higher prevalence of dyslipidemia in the patients with severe IM disease (66% vs 43%; P = .003). Most patients in both groups had had a WIfI (Wound, Ischemia, foot Infection) score of 4 (severe IM disease, 64%; vs mild to moderate IM disease, 57%; P = .462) and GLASS (global limb anatomic severity scale) III anatomy (severe IM disease, 54%; vs mild to moderate IM disease, 48%; P = .752). The Kaplan-Meier estimates showed that severe IM disease was associated with lower freedom from MALE (69% vs 82%; P = .026). The Cox proportion hazard regression model showed that severe IM disease was an independent predictor of increased MALE and amputation risk (hazard ratio, 1.715; 95% confidence interval, 1.015-2.896; P = .044) after adjusting for covariates. During follow-up, patients with severe IM disease had had mortality (27% vs 31%; P = .567) and reintervention (42% vs 38%; P = .608) similar to those for patients with mild to moderate IM disease. Primary limb-based patency was also similar (79% vs 84%; P = .593) at a mean follow-up of 3.8 ± 0.8 years. CONCLUSIONS: Severe IM disease was prevalent in 43% of limbs that had undergone endovascular revascularization for CLTI and was associated with lower freedom from MALE. Severe IM disease also independently increased the hazard of adverse limb outcomes and amputations in patients with CLTI by >70%, highlighting its importance as a measure of foot perfusion.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Naiem AA, Bergeron A, MacKenzie KS, et al. Severe inframalleolar disease is an independent predictor of adverse limb outcomes after endovascular revascularization in chronic limb-threatening ischemia. J Vasc Surg. 2022. PMID: 36332807. doi:10.1016/j.jvs.2022.10.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。